Background {#section1-1559325817746303}
==========

The first analysis of long-term exposures to air pollution and risk of mortality using the American Cancer Society Cancer Prevention Study II (ACS CPS-II) cohort was published in 1995.^[@bibr1-1559325817746303]^ Subsequently, extensive independent reanalysis^[@bibr2-1559325817746303]^ and multiple extended analyses^[@bibr3-1559325817746303][@bibr4-1559325817746303][@bibr5-1559325817746303][@bibr6-1559325817746303]-[@bibr7-1559325817746303]^ were conducted. These studies have consistently demonstrated that exposure to fine particulate matter air pollution (PM~2.5~) is associated with increased risk of mortality, especially cardiopulmonary or cardiovascular disease mortality. A recent analysis by Enstrom, based on early data from the ACS CPS-II cohort, reports no significant relationship between PM~2.5~ and total mortality.^[@bibr8-1559325817746303]^ The author asserts that the original analyses, reanalyses, and the extended analyses found positive PM~2.5~--mortality relationships because of selective use of CPS-II and PM~2.5~ data.

Expanded Analyses of the ACS CPS-II Cohort {#section2-1559325817746303}
==========================================

The assertion regarding selective use of the CPS-II and PM~2.5~ data is false. The scope of analyses of the ACS CPS-II cohort conducted over more than 2 decades were explicitly expanded over time to characterize population health risks of PM~2.5~ in more detail and with greater accuracy. [Table 1](#table1-1559325817746303){ref-type="table"} provides an outline of key published studies of this expansive body of air pollution research. The highlights of the obvious progress made during the course of these studies include the following:increased mortality follow-up from 7 to 22 or 26 years;increased number of participants included in the analyses from approximately 295 000 to 670 000;increased number of deaths (a key determinant of study power) included in the analyses from approximately 21 000 to 237 000;improved assessment of PM~2.5~ exposures (and exposures of co-pollutants) from metro-level averages for cities with air pollution monitoring to modeled PM~2.5~ exposures at geocoded residential addresses throughout the United States; andimproved statistical models, including improved control for individual and ecological covariates, and better representation of spatial patterns in the data.

###### 

Overview of Key Studies of Particulate Matter Air Pollution and Risk of Mortality Using the ACS CPS-II Cohort.

![](10.1177_1559325817746303-table1)

  Citation                                                                                Authors          Approx. No. Participants (Deaths) for Key PM Measures      Geographic Units of Exposure                                                        Years of Follow-Up   Comments
  --------------------------------------------------------------------------------------- ---------------- ---------------------------------------------------------- ----------------------------------------------------------------------------------- -------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Am J Respir Crit Care Med.* 1995;151:669-674.^[@bibr1-1559325817746303]^               Pope et al       PM~2.5~: 295 000 (21 000) SO~4~: 550 000 (39 000)          50 metro areas 151 metro areas in the United States                                 7 (1982-1989)        Original analysis. Mortality, especially cardiopulmonary, associated with PM~2.5~ and SO~4~
  Health Effects Institute 2000; HEI Special Report.^[@bibr2-1559325817746303]^           Krewski et al    PM~2.5~: 300 000 (23 000) SO~4~: 559 000 (43 000)          50 metro areas 151 metro areas in the United States                                 7 (1982-1989)        Independent reanalysis that substantively reproduced original results, developed improved modeling, and provided substantial sensitivity analysis
  *JAMA.* 2002;287:1132-1141.^[@bibr3-1559325817746303]^                                  Pope et al       PM~2.5~: 500 000 SO~4~: 560 000                            116 metro areas 149 metro areas in the United States                                16 (1982-1998)       All-cause, lung-cancer, and cardiopulmonary mortality, associated with PM~2.5~ and SO~4~. Improved statistical modeling, including random effects
  *Circulation.* 2004;109:71-77.^[@bibr9-1559325817746303]^                               Pope et al       PM~2.5~: 500 000                                           116 metro areas in the United States                                                16 (1982-1998)       PM~2.5~ associated with cardiovascular mortality. Evidence of pathophysiological pathways of disease explored
  *Epidemiology.* 2005;16:727-736.^[@bibr10-1559325817746303]^                            Jerrett et al    PM~2.5~: 23 000 (6000)                                     267 zip code areas in metro Los Angeles                                             18 (1982-2000)       Relatively large PM~2.5~ associations with all-cause, lung-cancer, and cardiopulmonary mortality
  *Lancet.* 2009;374:2091-2103.^[@bibr11-1559325817746303]^                               Smith et al      PM~2.5~. SO~4~, and elemental carbon: 350 000 (93 000)     86 metro areas in the United States                                                 18 (1982-2000)       Cardiopulmonary mortality was associated with PM~2.5~, SO~4~, and elemental carbon. Correlations across pollutants make independent estimates difficult
  Health Effects Institute 2009; Research Report Number 140.^[@bibr4-1559325817746303]^   Krewski et al    PM~2.5~: 500 000 SO~4~: 560 000                            116 metro areas 147 metro areas in the United States                                18 (1982-2000)       All-cause, lung-cancer, and cardiopulmonary mortality associated with PM~2.5~ and SO~4~ even controlling for ecologic covariates
  *N Engl J Med.* 2009;360:1085-1095.^[@bibr5-1559325817746303]^                          Jerrett et al    PM~2.5~: 450 000 (118 000)                                 86 metro areas in the United States                                                 18 (1982-2000)       Evaluated associations with ozone, independent of PM~2.5~, however, PM~2.5~--mortality associations were observed as in previous studies
  *Am J Respir Crit Care Med.* 2011;184:1374-1381.^[@bibr12-1559325817746303]^            Turner et al     PM~2.5~: 178 000 never smokers (1000 lung cancer deaths)   117 metro areas in the United States                                                26 (1982-2008)       Long-term exposure to PM~2.5~ pollution was associated with small but significant increase in risk of lung cancer mortality
  *Am J Respir Crit Care Med.* 2013;188:593-599.^[@bibr13-1559325817746303]^              Jerrett et al    PM~2.5~: 74 000 (20 000)                                   Modeled exposures at geocoded home addresses throughout California                  18 (1982-2000)       Based on individualized exposure assignments at home addresses, mortality risk was associated with air pollution, including PM~2.5~
  *Am J Epidemiol.* 2014;180:1145-1149.^[@bibr14-1559325817746303]^                       Turner et al     PM~2.5~: 430 000                                           Modeled PM~2.5~ exposures at geocoded home addresses throughout the United States   6 (1982-1988)        Evaluated the interactions between cigarette smoking and PM~2.5~ exposures for lung cancer mortality
  *Circulation Res.* 2015;116:108-115.^[@bibr6-1559325817746303]^                         Pope et al       PM~2.5~: 670 000 (237 000)                                 Modeled PM~2.5~ exposures at geocoded home addresses throughout the United States   22 (1982-2004)       The associations between all-cause and cardiovascular mortality and PM~2.5~ were similar to previous studies but, given the very large cohort and large number of deaths, the statistical precision of the estimate was remarkable
  *Environ Health Perspect.* 2016;124:785-794.^[@bibr15-1559325817746303]^                Thurston et al   PM~2.5~: 446 000                                           100 metro areas in the United States                                                22 (1982-2004)       Evaluated source-related components of PM~2.5~. Exposures from fossil fuel combustion, especially coal burning and traffic were associated with increased ischemic heart disease mortality
  *Am J Respir Crit Care Med.* 2016;193:1134-1142.^[@bibr16-1559325817746303]^            Turner et al     PM~2.5~: 670 000 (237 000)                                 Modeled PM~2.5~ exposures at geocoded home addresses throughout the United States   22 (1982-2004)       The focus of this study was on ozone exposure but mortality was associated with PM~2.5~ (both near-source and regional) as observed previously
  *Environ Res*. 2017;154:304-310.^[@bibr17-1559325817746303]^                            Turner et al     PM~2.5~: 429 000 (146 000) Current or never smokers        Modeled PM~2.5~ exposures at geocoded home addresses throughout the United States   22 (1982-2004)       Evaluated interactions between cigarette smoking and PM~2.5~. PM~2.5~ was associated with all-cause and cardiovascular mortality in both smokers and never smokers with evidence for a small additive interaction
  *Environ Health Perspect.* 2017;125:552-559.^[@bibr7-1559325817746303]^                 Jerrett et al    PM~2.5~: 670 000 (237 000)                                 Modeled PM~2.5~ exposures at geocoded home addresses throughout the United States   22 (1982-2004)       PM~2.5~ exposures assigned to using 7 exposure models and 11 exposure estimates. PM~2.5~--mortality risks were observed using all of the exposure models. Smaller associations observed using remote sensing exposure estimates; larger effects observed using exposure models that included ground-based information
  *Dose-Response.* 2017;15(1):1-12.^[@bibr8-1559325817746303]^                            Enstrom          PM~2.5~: 270 000 (16 000)                                  85 counties in the United States                                                    6 (1982-1988)        Asserted no significant mortality associations using "best" PM~2.5~ data

Abbreviations: ACS CPS II, American Cancer Society Cancer Prevention Study II; PM~2.5~, particulate matter air pollution.

As shown in [Figure 1](#fig1-1559325817746303){ref-type="fig"}, estimates of the percentage increase in mortality risk per 10 µg/m^3^ increase in PM~2.5~ for all-cause and for cardiovascular disease mortality from studies using the ACS CPS-II cohort have been remarkably consistent across the expanded analyses over the last 20+ years. The recent analysis by Enstrom^[@bibr8-1559325817746303]^ shows an estimated PM~2.5~--mortality association that is smaller than observed in the original analysis, the reanalysis, multiple subsequent extended analyses, or meta-analyses of studies throughout the world.^[@bibr18-1559325817746303]^

![Nationwide estimates of percentage increase in mortality risk per 10 µg/m^3^ increase in PM~2.5~ from various published studies using the ACS CPS-II cohort (indicated by circles) with comparison estimates from meta-analysis of the literature (indicated by diamonds). The size of the circles is relative to the length of the follow-up period. Gray and white circles indicate metro-level and county-level geographic units of exposure, respectively. Black circles indicate that exposures were modeled at geocoded residential addresses. Asterisks indicate that, in addition to controlling for individual covariate, the models also controlled for ecological covariates. Note. (1) Krewski et al^[@bibr2-1559325817746303]^ report the results of an independent, confirmatory reanalysis of the ACS cohort organized by the Health Effects Institute. (2) In the investigation of alternative measures of PM~2.5~ conducted by Jerrett et al,^[@bibr7-1559325817746303]^ the highest quality models (those with the lowest AIC) produced the highest risk estimates; remote sensing models with no ground-based data produced the lowest risk estimates, likely because of greater exposure misclassification. (3) The lowest risk estimate reported by Enstrom^[@bibr8-1559325817746303]^ is based on a dated and short follow-up of the ACS cohort and is likely subject to exposure mismatching. ACS CPS II indicates American Cancer Society Cancer Prevention Study II; PM~2.5~, particulate matter air pollution.](10.1177_1559325817746303-fig1){#fig1-1559325817746303}

Deficiencies in Enstrom's Reanalysis {#section3-1559325817746303}
====================================

Enstrom's recently published analysis^[@bibr8-1559325817746303]^ is the least advanced analysis of the ACS CPS-II cohort to date (see [Table 1](#table1-1559325817746303){ref-type="table"}). The Enstrom's analysis uses a data set with a shorter follow-up period, fewer participants, and fewer deaths than any previous PM~2.5~--mortality analyses that used the CPS-II cohort, including the original 1995 analysis. He controls for a relatively limited number of individual-level covariates and does not control for any ecologic covariates. Moreover, the key deficiency in the Enstrom's reanalysis is the absence of advanced modeling approaches for exposure assessment that have been developed over the last 2 decades. Estimates of PM~2.5~--mortality associations are affected by the quality of the PM~2.5~ data and the accuracy of matching participants and exposures. In a recent analysis,^[@bibr7-1559325817746303]^ we evaluated PM~2.5~ exposures using multiple exposure assessment methods. [Figure 1](#fig1-1559325817746303){ref-type="fig"} illustrates that there were significant PM~2.5~--mortality risk associations for all PM~2.5~ measures, but the associations were lower for the presumably less accurate measures that used remote sensing without ground-based data. Based on measures of model quality, the PM~2.5~ exposure values that best fit (lowest Akaike Information Criteria, AIC) the data resulted in relatively larger PM~2.5~--mortality associations (see [Figure 1](#fig1-1559325817746303){ref-type="fig"}). In contrast, Enstrom^[@bibr8-1559325817746303]^ asserts that he estimates smaller PM~2.5~--mortality associations because he uses the "best" PM~2.5~ data. He provides neither evidence in support of this assertion nor any measures of the relative quality of models using alternative PM~2.5~ data. It is not clear how or why his "IPN" PM~2.5~ data differ from the "Health Effects Institute" PM~2.5~ data---especially given that these data come from the same monitoring network.

Furthermore, Enstrom's PM~2.5~ exposure assessment is likely subject to greater exposure misclassification because of inadequate assignment of geographic units of exposure. Although other published ACS CPS-II studies assigned geographic areas of exposure based on participants' residence information, the Enstrom's analysis used the ACS Division and Unit numbers to assign PM~2.5~ exposures (see letter from ACS). The ACS Division and Unit numbers, however, were for the ACS volunteers that recruited the participants. These volunteers did not always live in the same area or even in the same state as the participants. Enstrom does not document the extent of this participant-exposure mismatching, but it has the potential for substantial exposure misclassification and resultant attenuation bias. Our published research using the ACS CPS-II data is based on participant-exposure matching that is accurate, includes highly spatially resolved exposure models, and utilizes ground-based monitoring and land use data.

An inexplicable deficiency of the Enstrom's article is its inadequate documentation of the relevant and extensive peer-reviewed literature. References provided in the article largely include an unconventional mix of unpublished and non-peer-reviewed correspondence (including letters, e-mails, and transcript of a teleconference call), presentation slides, press releases, and a compilation of manuscript rejections. Key published extended analyses of the ACS CPS-II cohort,^[@bibr3-1559325817746303],[@bibr5-1559325817746303],[@bibr6-1559325817746303],[@bibr7-1559325817746303],[@bibr9-1559325817746303][@bibr10-1559325817746303][@bibr11-1559325817746303][@bibr12-1559325817746303][@bibr13-1559325817746303][@bibr14-1559325817746303][@bibr15-1559325817746303][@bibr16-1559325817746303]-[@bibr17-1559325817746303]^ studies of other cohorts,^[@bibr18-1559325817746303][@bibr19-1559325817746303][@bibr20-1559325817746303][@bibr21-1559325817746303][@bibr22-1559325817746303][@bibr23-1559325817746303][@bibr24-1559325817746303][@bibr25-1559325817746303][@bibr26-1559325817746303][@bibr27-1559325817746303][@bibr28-1559325817746303][@bibr29-1559325817746303][@bibr30-1559325817746303]-[@bibr31-1559325817746303]^ or even major reviews and evaluations of the literature^[@bibr32-1559325817746303],[@bibr33-1559325817746303]^ are not cited or discussed.

Broader Evidence {#section4-1559325817746303}
================

The PM~2.5~--mortality associations observed from the various analyses of the ACS CPS-II cohort are consistent with a much broader body of evidence from other studies. As examples, these include studies of other cohorts from the United States^[@bibr19-1559325817746303][@bibr20-1559325817746303][@bibr21-1559325817746303][@bibr22-1559325817746303][@bibr23-1559325817746303][@bibr24-1559325817746303][@bibr25-1559325817746303]-[@bibr26-1559325817746303]^ Europe,^[@bibr27-1559325817746303][@bibr28-1559325817746303]-[@bibr29-1559325817746303]^ and Canada.^[@bibr30-1559325817746303],[@bibr31-1559325817746303]^ In addition, meta-analytic estimates of the PM~2.5~--mortality associations based on a 2013 meta-analysis of the overall literature^[@bibr18-1559325817746303]^ are also provided for comparison purposes in [Figure 1](#fig1-1559325817746303){ref-type="fig"}.

Previous studies of the ACS CPS-II cohort consistently demonstrated PM~2.5~--mortality associations with cardiovascular mortality.^[@bibr7-1559325817746303],[@bibr9-1559325817746303]^ There has also been substantial work in exploring and understanding the biological pathways and mechanisms linking PM~2.5~ exposures and cardiovascular disease and death.^[@bibr32-1559325817746303][@bibr33-1559325817746303][@bibr34-1559325817746303]-[@bibr35-1559325817746303]^ Similarly, the ACS CPS-II cohort has demonstrated PM~2.5~--mortality associations with lung cancer mortality,^[@bibr3-1559325817746303],[@bibr12-1559325817746303],[@bibr14-1559325817746303]^ and recently, the International Agency for Research on Cancer concluded, based on multiple sources of evidence, that particulate matter in outdoor air pollution is a cause of human lung cancer (group 1).^[@bibr36-1559325817746303]^ Enstrom^[@bibr8-1559325817746303]^ presents no results for cardiovascular or lung cancer mortality and largely dismisses the substantial and growing literature regarding relevant pathophysiological pathways and related biological mechanisms.

The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (conducted by the Institute for Health Metrics and Evaluation) identified ambient PM~2.5~ air pollution as the 5th leading risk factor for global mortality, contributing to approximately 4.2 million deaths in 2015.^[@bibr37-1559325817746303],[@bibr38-1559325817746303]^ These results are based on recent and comprehensive estimates from ACS CPS-II cohort studies and 23 other peer-reviewed studies of long-term exposure to PM~2.5~ and mortality from cause-specific cardiovascular and respiratory disease and lung cancer. These results underscore the importance of PM~2.5~ as a substantial determinant of mortality in the general population. Consequently, these results also suggest substantial health benefits from further reductions in ambient air pollution.

In summary, we welcome thoughtful criticism of our research. But the study by Enstrom does not contribute to the larger body of evidence on the health effects of PM~2.5~, as it does not utilize adequate approaches for exposure assessment, suitable methods for linking participants to exposure, and sufficient statistical control for potential confounding factors and fails to recognize the larger body of evidence on PM~2.5~ exposure and disease risk.
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